Honeycomb biotechnologies and revvity launch new solutions to expand the frontiers of single cell research

Waltham, mass.--(business wire)--today, in collaboration with single cell genomics company, honeycomb biotechnologies (“honeycomb”), revvity (nyse: rvty) announced the launch of a suite of new solutions and services that expand the frontiers of single cell biology: the hive™ clx single-cell rnaseq solution, beenetplus analysis workflow, and for single cell researchers based in the united states, a new hive clx service offering. the hive clx single-cell rnaseq solution offers higher density sing.
RVTY Ratings Summary
RVTY Quant Ranking